News

Declining investment in global health surveillance, research, and scientific innovation are happening as the need for vigilance has never been greater, writes Robert C. Gallo.
Part of the nation’s suicide and crisis hotline that was specifically aimed at helping LGBTQ+ youth was shut down this week, ...
Harvard University appears in federal court Monday, challenging $2.6 billion in funding cuts by the Trump administration.
The Food and Drug Administration named a longtime pharmaceutical executive to run the agency’s drug program. Dr.
HARVARD LAWSUIT: A federal judge appeared to lean in favor of Harvard University during arguments today in its lawsuit over ...
Designed for daily cognitive support, BrainDefender offers a clean-label alternative to stimulant-based brain supplements ...
Brain health isn’t just an elderly concern. In early childhood, poor maternal nutrition and infections can cause lifelong ...
Hone Health reports that the controversial 2002 WHI study misled menopause care, linking HRT to breast cancer and causing ...
Regulators plan to integrate ibogaine treatment into Colorado’s psychedelic healing industry. Still, the drug faces an uncertain future.
Food and Drug Administration commissioner Marty Makary has chosen former biotech executive George Tidmarsh as the agency’s top drug regulator, the agency confirmed Monday.
The findings suggest potential new reasons for mental health challenges of veterans exposed to toxic chemicals while in the ranks.
Beaches face escalating risks from microbial contamination due to climate change and human activity, increasing the burden of ...